Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo

Journal of Experimental Medicine

Volumn 182, Issue 4, 1995, Pages 1169-1174

  Collins, P D ^a   Marleau, S ^a   Griffiths Johnson, D A ^a   Jose, P J ^a   Williams, T J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; EOTAXIN; RECOMBINANT INTERLEUKIN 5;

ALLERGY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW; DRUG EFFECT; EOSINOPHILIA; FEMALE; GUINEA PIG; INTRADERMAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION;

ANIMAL; BONE MARROW; BONE MARROW CELLS; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EOSINOPHILIA; EOSINOPHILS; GUINEA PIGS; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAVENOUS; INTERLEUKIN-5; LEUKOTRIENE B4; MALE; PEROXIDASES; SKIN; SUPPORT, NON-U.S. GOV'T;

EID: 0029148025     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.182.4.1169     Document Type: Article

References (34)

1. Sanderson, C.J., D.G. Warren, and M. Strath. 1985. Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures. J. Exp. Med. 162: 60-74.
2. Clutterbuck, E.J., and C.J. Sanderson. 1988. Human eosinophil hematopoiesis studied in vitro by means of murine eosinophil differentiation factor (IL-5): production of functionally active eosinophils from normal human bone marrow. Blood. 71: 646-651.
3. Yamaguchi, Y., T. Suda, J. Suda, M. Eguchi, Y. Miura, N. Harada, A. Tominaga, and K. Takatsu. 1988. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med. 167: 43-56.
4. Sehmi, R., A.J. Wardlaw, O. Cromwell, K. Kurihara, P. Waltmann, and A.B. Kay. 1992. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood. 79: 2952-2959.
5. Warringa, R.A.J., H.J.J. Mengelers, P.H.M. Kuijper, J.A.M. Raaijmakers, P.L.B. Bruijnzeel, and L. Koenderman. 1992. In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals. Blood. 79: 1836-1841.
6. Coeffier, E., D. Joseph, and B.B. Vargaftig. 1991. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists. J. Immunol. 147: 2595-2602.
7. Tai, P.C., L. Sun, and C.J.F. Spry. 1991. Effects of IL-5, gran-ulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro. Clin. Exp. Immunol. 85: 312-316.
8. Coffman, R.L., B.W.P. Seymour, S. Hudak, J. Jackson, and D. Rennick. 1989. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science (Wash. DC). 245: 308-310.
9. Sedgwick, J.B., W.J. Calhoun, G.J. Gleich, H. Kita, J.S. Abrams, L.B. Schwartz, B. Volovitz, M. Ben-Yaakov, and W.W. Busse. 1991. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Am. Rev. Respir. Dis. 144: 1274-1281.
10. Hamid, Q., M. Azzawi, S. Ying, R. Moqbel, A.J. Wardlaw, C.J. Corrigan, B. Bradley, S.R. Durham, J.V. Collins, P.K. Jeffery, D.J. Quint, and A.B. Kay. 1991. Interleukin-5 in the pathogenesis of asthma. J. Clin. Invest. 87: 1541-1546.
11. Krishnaswamy, G., M.C. Liu, S.-N. Su, M. Kumai, H.-Q. Xiao, D.G. Marsh, and S.-K. Huang. 1993. Analysis of cytokine transcripts in the bronchoalveolar lavage cells of patients with asthma. Am.J. Respir. Cell Mol. Biol. 9: 279-286.
12. Kay, A.B., S. Ying, V. Vamey, M. Gaga, S.R. Durham, R. Moqbel, A.J. Wardlaw, and Q. Hamid. 1991. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J. Exp. Med. 173: 775-778.
13. Dubucquoi, S., P. Desreumaux, A. Janin, O. Klein, M. Goldman, J. Tavernier, A. Capron, and M. Capron. 1994. Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J. Exp. Med. 179: 703-708.
14. Desreumaux, P., A. Janin, S. Dubucquoi, M.-C. Copin, G. Torpier, A. Capron, M. Capron, and L. Prin. 1993. Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases. Blood. 82: 1553-1560.
15. Broide, D.H., M.M. Paine, and G.S. Firestein. 1992. Eosinophils express interleukin 5 and granulocyte macrophage-colony-simulating factor mRNA at sites of allergic inflammation in asthmatics. J. Clin. Invest. 90: 1414-1424.
16. Yamaguchi, S., H. Nagai, H. Tanaka, M. Tsujimoto, and N. Tsuruoka. 1994. Time course study for antigen-induced airway hyperreactivity and the effect of soluble IL-5 receptor. Life Sciences. 54: 471-475.
17. Chand, N., J.E. Harrison, S. Rooney, J. Pillar, R. Jakubicki, K. Nolan, W. Diamantis, and R.D. Sofia. 1992. Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pigs: a therapeutic approach. Eur. J. Pharmacol. 211: 121-123.
18. Van Oosterhout, A.J.M., R.S. Ladenius, H.F.J. Savelkoul, I. Van Ark, K.C. Delsman, and F.P. Nijkamp. 1993. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am. Rev. Respir. Dis. 147: 548-552.
19. Mauser, P.J., A. Pitman, A. Witt, X. Fernandez, J. Zurcher, T. Kung, H. Jones, A.S. Watnick, R.W. Egan, W. Kreutner, and K.G. Adams. 1993. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am. Rev. Respir. Dis. 148: 1623-1627.
20. Coeffier, E., D. Joseph, and B.B. Vargaftig. 1994. Role of Interleukin-5 in enhanced migration of eosinophils from airways of immunized guinea-pigs. Br. J. Pharmacol. 113: 749-756.
21. Iwama, T., H. Nagai, H. Suda, N. Tsuruoka, and A. Koda. 1992. Effect of murine recombinant interleukin-5 on the cell population in guinea-pig airways. Br. J. Pharmacol. 105: 19-22.
22. Yamaguchi, Y., Y. Hayashi, Y. Sugama, Y. Miura, T. Kasahara, S. Kitamura, M. Torisu, S. Mita, A. Tominaga, K. Takatsu, and T. Suda. 1988. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J. Exp. Med. 167: 1737-1742.
23. Wang, J.M., A. Rambaldi, A. Biondi, Z.G. Chen, C.J. Sanderson, and A. Mantovani. 1989. Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur. J. Immunol. 19: 701-705.
24. Jose, P.J., D.A. Griffiths-Johnson, P.D. Collins, D.T. Walsh, R. Moqbel, N.F. Totty, O. Truong, J.J. Hsuan, and T.J. Williams. 1994. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea-pig model of allergic airways inflammation. J. Exp. Med. 179: 881-887.
25. Griffiths-Johnson, D.A., P.D. Coffins, A.G. Rossi, P.J. Jose, and T.J. Williams. 1993. The chemokine, Eotaxin, activates guinea-pig eosinophils in vitro, and causes their accumulation into the lung in vivo. Biochem. Biophys. Res. Commun. 197: 1167-1172.
26. Jose, P.J., I.M. Adcock, D.A. Griffiths-Johnson, N. Berkman, T.N.C. Wells, T.J. Williams, and C.A. Power. 1994. Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs. Biochem. Biophys. Res. Commun. 205: 788-794.
27. Pettipher, E.R., E.D. Salter, and H.J. Showell. 1994. Effect of in vivo desensitization to leukotriene B4 on eosinophil infiltration in response to C5a in guinea-pig skin. Br.J. Pharmacol. 113: 117-120.
28. Strath, M., D.J. Warren, and C.J. Sanderson. 1985. Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiation factors. J. Immunol. Methods. 83: 209-215.
29. Faccioli, L.H., S. Nourshargh, R. Moqbel, F.M. Williams, R. Sehmi, A.B. Kay, and T.J. Williams. 1991. The accumulation of mIn-eosinophils induced by inflammatory mediators in vivo. Immunology. 73: 222-227.
30. Sanjar, S., P. McCabe, and L. Reynolds. 1992. Recombinant human IL-5 (rh-IL5) induces a rapid and selective blood eosinophilia in the guinea-pig. Am. Rev. Respir. Dis. (Proc. Suppl.) 143: A14P. (Abstr.)
31. Hudson, G. 1963. Changes in the bone marrow reserve of eosinophils following re-exposure to foreign protein. Br. J. Haematol. 9: 446-455.
32. Hudson, G. 1964. The marrow reserve of eosinophils. Effect of cortical hormones on the foreign protein response. Br. J. Haematol. 10: 122-130.
33. Schweizer, R.C., B.A.C. Welmers, J.A.M. Raaijmakers, P. Zanen, J.-W.J. Lammers, and L. Koenderman. 1994. RANTES-and interleukin-8-induced responses in normal human eosinophils: effects of priming with interleukin-5. Blood. 83: 3697-3704.
34. Ebisawa, M., M.C. Liu, T. Yamada, M. Kato, L.M. Lichtenstein, B.S. Bochner, and R.P. Schleimer. 1994. Eosinophil transendothelial migration induced by cytokines II. Potentiation of eosinophil transendothelial migration by eosinophil-active cytokines. J. Immunol. 152: 4590-4596.